FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082241 [Registered on: 12/03/2025] Trial Registered Prospectively
Last Modified On: 11/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Single Arm Study 
Public Title of Study   Clinical study to evaluate the efficacy of herbal hair oil in the patient of hair fall 
Scientific Title of Study   Clinical trial to evaluate the efficacy of polyherbal hair oil(Habbul As, Amla, Mazu, Roghan kunjad) for Intithar al-Shar (diffuse hair loss): A Single arm, interventional study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Zaffar Hussain  
Designation  Professor Department of Moalajat  
Affiliation  Regional Research Institute of Unani Medicine (RRIUM), srinagar  
Address  Department of Moalajat RRIUM Naseem Bagh Campus of University of Kashmir Srinagar Jammu and Kashmir

Srinagar
JAMMU & KASHMIR
190006
India 
Phone  7006021996  
Fax    
Email  hussainzaffar6@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Zaffar Hussain  
Designation  Professor Department of Moalajat  
Affiliation  Regional Research Institute of Unani Medicine (RRIUM), srinagar  
Address  Department of Moalajat RRIUM Naseem Bagh Campus of University of Kashmir Srinagar Jammu and Kashmir


JAMMU & KASHMIR
190006
India 
Phone  7006021996  
Fax    
Email  hussainzaffar6@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sadiya Khatoon 
Designation  PG Scholar 
Affiliation  Regional Research Institute of Unani Medicine (RRIUM), srinagar  
Address  Department of Moalajat RRIUM Naseem Bagh Campus of University of Kashmir Srinagar Jammu and Kashmir

Srinagar
JAMMU & KASHMIR
190006
India 
Phone  9013389539  
Fax    
Email  sadiya.tibb@gmail.com  
 
Source of Monetary or Material Support  
Central Council for Research In Unani Medicine (CCRUM), New Delhi- 110058 
 
Primary Sponsor  
Name  Central Council for Research In Unani Medicine CCRUM New Delhi  
Address  Regional Research Institute of Unani Medicine (RRIUM), University of Kashmir Srinagar- 190006 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Zaffar Hussain  Regional Research Institute of Unani Medicine (RRIUM), Srinagar  Moalajat opd-1, ground floor department of moalajat RRIUM naseembagh campus University of kASHMIR hazratbal
Srinagar
JAMMU & KASHMIR 
7006021996

hussainzaffar6@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L659||Nonscarring hair loss, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not applicable   Not applicable  
Intervention  Roghan (oil)  It is a classical unani formulation taken from Al- Hawi. The formulation comprises of three single herbal drug namely Habbul As (Myrtus communis),Amla (Emblica officinalis), Mazu (Quercus infectoria olivier) in a compound drug Roghan kunjad (Sesamum indicum). The formulation will be given at bedtime 10 ml for local application on scalp with gentle massage daily for 2 month  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  Male and female Patients of age between 18-40 years.
Hair loss more than 100 strands per day. Patients who are willing to give consent and are able to follow up
 
 
ExclusionCriteria 
Details  Known cases of hypothyroidism. Patients with male androgenetic alopecia, seborrhic dermatitis, lichen planopilaris, scalp psoriasis, tinea capitis, alopecia areata, trichotillomania & scaring alopecia .Patients with surgical correction of scalp hair loss (hair transplant)
Patients who fail to give written consent.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1) Hair shedding Visual Scale
2) Trichoscopy 
2 month 
 
Secondary Outcome  
Outcome  TimePoints 
1) Hair pull test
2) Investigator Assessment using Photograph 
2 month 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 Hair loss is a normal physiological function of the body because of the asynchronous nature of the human hair cycle. Upto 100  hair often fall out each day. Increased hair loss over 100 hairs per day is a dermatological condition that affects both men and women. Diffuse hair loss (DHL) is a highly frequent and difficult issue that affects both gender , but young to middle-aged women are  more noticeable in this age group. Commonest DHL is chronic telogen effluvium(CTE) followed by female pattern hair loss (FPHL) and acute telogen effluvium(ATE). In Unani System of Medicine, hair loss is termed as Intithar al- SharUnani physicians have been treating this disease by different means and they have mentioned various Unani drugs (single as well as compound) in the literature for its treatment. The present medical system does not have a specific treatment for it. Therefore, the proper topical combination with a multi targeted approach may improve hair loss and achieve a quicker outcome.

Keeping in view the above mentioned facts, it has been decided to evaluate the efficacy of poly herbal hair oil  in the management of Intithar al-Shar (diffuse hair loss).

 
Close